Two Bold Predictions for the U.S. BioPharma Industry During Trump's 1st 100 Days

The December 4, 2024, Mar-a-lago meeting with BioPharma execs wasn't about curing cancer. It was about cutting ties with China and pulling the mRNA shots off of the market.

Dec 15, 2024

∙ Paid

December 14, 2024: Greg Hunter and I sat down to discuss December 4, 2024, Mar-a-lago meeting with BioPharma execs and what’s in store for Pfizer and the U.S. BioPharma industry during the first 100 days of the Trump administration after RFK Jr. becomes Secretary of Health & Human Services (HHS).

Two (2) Predictions Based on US Law, Government Documents…

Keep reading with a 7-day free trial

Subscribe to The Kingston Report to keep reading this post and get 7 days of free access to the full post archives.